文献速递心律失常血脂与心血管预防

房颤抗凝类型与痴呆风险:DOAC与VKA比较

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
PubMed 文献 · Heart · 2021-10-13

与VKA相比,DOAC治疗与痴呆诊断风险降低16%、轻度认知障碍风险降低26%相关。

要点

  • 新诊断房颤患者中,DOAC较VKA与痴呆风险降低16%相关。
  • DOAC较VKA与轻度认知障碍风险降低26%相关。
  • 结果在多项敏感性分析中一致。

核心结论

  • 在新诊断非瓣膜性房颤患者中,处方DOAC者发生电子健康记录记录的痴呆和轻度认知障碍的风险低于处方VKA者。

研究设计与样本

  • 利用英国临床实践研究数据链链接的电子健康记录数据,开展历史性队列研究。
  • 采用Cox比例风险回归模型,以年龄为基本时间尺度,校正日历时间、治疗时间、社会人口学与生活方式因素、临床合并症及用药。

主要发现

  • 整体有1258例(3.2%)出现全科医生记录的痴呆,发病率为16.5/1000人年。
  • 全队列中,DOAC治疗较VKA治疗与痴呆诊断风险降低16%相关(校正HR 0.84,95%CI:0.73至0.98)。
  • DOAC治疗较VKA治疗与轻度认知障碍风险降低26%相关(校正HR 0.74,95%CI:0.65至0.84)。
  • 各项敏感性分析结果相似。

临床怎么用

  • 对于新诊断非瓣膜性房颤需口服抗凝的患者,选择DOAC而非VKA可能有助于降低痴呆和轻度认知障碍风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the association between oral anticoagulant type (direct oral anticoagulants (DOACs) vs vitamin K antagonists (VKAs)) and incident dementia or mild cognitive impairment (MCI) among patients with newly diagnosed atrial fibrillation (AF). METHODS: Using linked electronic health record (EHR) data from the Clinical Practice Research Datalink in the UK, we conducted a historical cohort study among first-time oral anticoagulant users with incident non-valvular AF diagnosed from 2012 to 2018. We compared the incidence of (1) clinically coded dementia and (2) MCI between patients prescribed VKAs and DOACs using Cox proportional hazards regression models, with age as the underlying timescale, accounting for calendar time and time on treatment, sociodemographic and lifestyle factors, clinical comorbidities and medications. RESULTS: Of 39 200 first-time oral anticoagulant users (44.6% female, median age 76 years, IQR 68-83), 20 687 (53%) were prescribed a VKA and 18 513 (47%) a DOAC at baseline. Overall, 1258 patients (3.2%) had GP-recorded incident dementia, incidence rate 16.5 per 1000 person-years. DOAC treatment for AF was associated with a 16% reduction in dementia diagnosis compared with VKA treatment in the whole cohort (adjusted HR 0.84, 95% CI: 0.73 to 0.98) and with a 26% reduction in incident MCI (adjusted HR 0.74, 95% CI: 0.65 to 0.84). Findings were similar across various sensitivity analyses. CONCLUSIONS: Incident EHR-recorded dementia and MCI were less common among patients prescribed DOACs for new AF compared with those prescribed VKAs.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Cadogan SL, Powell E, Wing K, et al. Anticoagulant prescribing for atrial fibrillation and risk of incident dementia. Heart. 2021. PMID: 34645643. doi:10.1136/heartjnl-2021-319672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。